Sigma Planning Corp Sells 29,205 Shares of Kenvue Inc. (NYSE:KVUE)

Sigma Planning Corp reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 59.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,052 shares of the company’s stock after selling 29,205 shares during the period. Sigma Planning Corp’s holdings in Kenvue were worth $432,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Beaumont Financial Advisors LLC increased its stake in shares of Kenvue by 3.0% in the fourth quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock worth $377,000 after purchasing an additional 509 shares in the last quarter. Pinnacle Bancorp Inc. increased its stake in shares of Kenvue by 51.3% in the fourth quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock worth $33,000 after purchasing an additional 526 shares in the last quarter. Dfpg Investments LLC increased its stake in shares of Kenvue by 2.3% in the fourth quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock worth $567,000 after purchasing an additional 589 shares in the last quarter. Mutual Advisors LLC increased its stake in shares of Kenvue by 6.1% in the fourth quarter. Mutual Advisors LLC now owns 10,606 shares of the company’s stock worth $228,000 after purchasing an additional 612 shares in the last quarter. Finally, Baron Wealth Management LLC increased its stake in shares of Kenvue by 7.5% in the fourth quarter. Baron Wealth Management LLC now owns 12,915 shares of the company’s stock worth $278,000 after purchasing an additional 899 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

KVUE has been the subject of several recent research reports. The Goldman Sachs Group initiated coverage on shares of Kenvue in a research note on Friday, March 1st. They issued a “neutral” rating and a $20.00 target price for the company. William Blair assumed coverage on shares of Kenvue in a research note on Wednesday, April 3rd. They set a “market perform” rating for the company. Sanford C. Bernstein assumed coverage on shares of Kenvue in a research note on Thursday, April 11th. They set an “underperform” rating and a $18.00 price objective for the company. JPMorgan Chase & Co. reduced their price objective on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research note on Friday, February 9th. Finally, Royal Bank of Canada reduced their price objective on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $24.85.

Kenvue Trading Down 0.8 %

KVUE stock opened at $18.86 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.12 and a quick ratio of 0.78. Kenvue Inc. has a one year low of $17.82 and a one year high of $27.80. The firm has a 50 day simple moving average of $19.84 and a two-hundred day simple moving average of $20.13.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. The company had revenue of $3.67 billion for the quarter, compared to the consensus estimate of $3.78 billion. Kenvue had a net margin of 9.87% and a return on equity of 15.62%. The company’s revenue was down 2.7% on a year-over-year basis. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.24%. The ex-dividend date is Tuesday, May 7th.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.